Vincent Battista, PhD
About Vincent Battista, PhD
Vincent Battista, PhD, is a Senior Scientist in Translational Epidemiology at Bristol Myers Squibb, specializing in cardiovascular and inflammatory disease research.
Title
Vincent Battista, PhD, serves as a Senior Scientist in Translational Epidemiology at Bristol Myers Squibb. Based in Cambridge, Massachusetts, he brings specialized expertise in cardiovascular and inflammatory disease research.
Company
Vincent Battista currently works at Bristol Myers Squibb. His role centers around the translational epidemiology field, where he handles responsibilities related to multi-modal data and multi-omic analyses.
Education and Expertise
Vincent Battista holds a Doctor of Philosophy (PhD) in Physical and Biological Anthropology from the University of Michigan, earned over a period from 2015 to 2021. He completed his Masters of Science in Archaeological Science, specializing in Biological Anthropology, at Durham University from 2013 to 2014. Additionally, he holds a Bachelor of Arts in Physical and Biological Anthropology from the University of Connecticut, which he earned from 2009 to 2013.
Professional Background
Vincent Battista's professional background includes a diverse range of roles, highlighting his broad expertise in data analysis and bioinformatics. He previously worked at Mass General Hospital as a Bioinformatician/Senior Data Analyst, and at the University of Michigan in various positions including Graduate Student Instructor and Doctoral Student. Vincent has also held research roles at Yale University, Durham University, and University of Connecticut, demonstrating a strong foundation in both academic and applied research settings.
Research Focus and Specialization
Specializing in cardiovascular and inflammatory disease research, Vincent Battista employs real-world multi-modal data in his work. His expertise includes handling proteomic, genomic, and various imaging modalities, and advising on multi-omic analyses to drive decisions with stakeholders. He possesses a deep understanding of real-world evidence (RWE) and real-world data (RWD), which are crucial in his current role at Bristol Myers Squibb.